This level of control and precision has simply not been broadly available to the pharmaceutical industry before.
PRINT particles can be designed to address desired pharmacological benefits, such as optimizing the route of administration, improving solubility, enhancing stability or extending therapeutic effects, with the goal of improving efficacy, safety and convenience for the patient.
This simple, elegant solution is applicable across therapeutic areas, molecule and routes of administration, and offers the opportunity to engineer a range of medicines, including drugs and biologics, single agents and combinations, and vaccines.
Drug delivery technologies have been hampered in adapting to specific challenges, including the drug’s chemical properties. By controlling size, composition and/or shape, the PRINT technology can deliver on the potential of drug delivery to improve medicines broadly.
PRINT technology allows for rapid transition of PRINT-enabled therapies from the laboratory, to clinical development, to scalable commercial production.